Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Former InterMune CEO Sentenced To Probation, DoJ Reindicts Former GSK Attorney

This article was originally published in The Pink Sheet Daily

Executive Summary

Scott Harkonen gets three years probation with six months of home confinement for a misleading press release; Lauren Stevens is reindicted on charges of obstructing an investigation of off-label marketing.

You may also be interested in...

Does Former Warner Chilcott Exec’s Arrest Portend More Prosecutions?

Carl Reichel indicted for conspiring to pay kickbacks to physicians while firm pleads guilty to health care fraud; former DOJ attorneys provide insights on case.

Pharma Strikes Out At Supreme Court As Three Recent Cert Petitions Fail

Pfizer, Cephalon and former InterMune CEO Scott Harkonen will find no relief from the high court.

Off-Label Prosecutions Hinge On Patient Benefit, Government Attorneys Say

Federal prosecutors say they will not pursue False Claims Act cases in which off-label use is the standard of care and note that the Caronia decision will have little impact on investigations; First Amendment defense fails in Par and Harkonen cases.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts